ANEB - Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. (ANEB)

NCM · Common · CUSIP 034569103

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ANEB and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 034569103
Market Cap: Small Cap
IPO: 5/10/2021 · $7.00/share

Links: Home Page Investor Relations News

Business: Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction.

Company Contact

CEO: Richie Cunningham
CFO: Daniel George
Headquarters: 1017 Ranch Road 620 South, Suite 107, Lakeway, TX 78734
Phone: 512-598-0931
Investor Relations: Scott L. Anderson · 512-598-0931 · dan@anebulo.com
General Email: IR@anebulo.com
SEC EDGAR Filings: View filings »